Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.45 |
| ▸ | MAN2B1 | O00754 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6152816 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL30922986 | 0.83 | SLC18A3 (0.41) | SLC18A3 | |
| SCHEMBL11350359 | 0.81 | — | — | |
| SCHEMBL15865508 | 0.71 | SLC18A3 (0.35) | SLC18A3MAN2B1ALDH1A1 | |
| SCHEMBL701424 | 0.71 | SLC18A3 (0.35) | SLC18A3MAN2B1ALDH1A1 | |
| SCHEMBL2336833 | 0.67 | — | — | |
| SCHEMBL11086482 | 0.64 | SLC18A3 (0.38) | SLC18A3ALDH1A1 | |
| SCHEMBL27729 | 0.62 | — | — | |
| SCHEMBL31589383 | 0.60 | — | — | |
| SCHEMBL16570976 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458522-B1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM SPA (IT) | 2024-01-03 | — | — | EP | claimed |
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | ICROM S.P.A. (IT) | 2020-07-28 | — | — | US | claimed |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM S.P.A. (IT) | 2019-06-20 | — | — | US | claimed |
| US-9856364-B2 | Stabilized reversible polymer composition | XEROX CORPORATION (US) | 2018-01-02 | — | — | US | claimed |
| US-20140353549-A1 | STABILIZED REVERSIBLE POLYMER COMPOSITION | XEROX CORPORATION (US) | 2014-12-04 | — | — | US | claimed |
| EP-0717054-A2 | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1996-06-19 | — | — | EP | claimed |
| US-5449724-A | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1995-09-12 | — | — | US | claimed |
| EP-3458522-B1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM SPA (IT) | 2024-01-03 | — | — | EP | disclosed |
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | ICROM S.P.A. (IT) | 2020-07-28 | — | — | US | disclosed |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM S.P.A. (IT) | 2019-06-20 | — | — | US | disclosed |
| US-9856364-B2 | Stabilized reversible polymer composition | XEROX CORPORATION (US) | 2018-01-02 | — | — | US | disclosed |
| US-20150337147-A1 | REVERSIBLE POLYMERS IN 3-D PRINTING | XEROX CORPORATION (US) | 2015-11-26 | — | — | US | disclosed |
| US-9193139-B2 | Reversible polymer adhesive composition | XEROX CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2004101562-A2 | BRIDGED N-ARYLSULFONYLPIPERIDINES AS GAMMA-SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040229902-A1 | Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors | SCHERING CORPORATION | 2004-11-18 | — | — | US | disclosed |
| US-6156858-A | Stable free radical polymerization processes | XEROX CORPORATION (US) | 2000-12-05 | — | — | US | disclosed |
| EP-0780733-A1 | Polymerization multiblock copolymer process and compositions thereof | XEROX CORPORATION (US) | 1997-06-25 | — | — | EP | disclosed |
| US-5552502-A | Polymerization process and compositions thereof | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0717054-A2 | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1996-06-19 | — | — | EP | disclosed |
| US-5449724-A | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1995-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | DDT, QDPR, DDC | SLC18A3 2819/4885MAN2B1 1985/4885TDP1 1351/4885 |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | DDT, QDPR, DDC | SLC18A3 2819/4885MAN2B1 1985/4885TDP1 1351/4885 |
| US-20040229902-A1 | Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors | BACE1, BACE2, PSEN1 | SLC18A3 3598/4885MAN2B1 558/4885TDP1 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.